Network Analysis of Comorbidities: Case Study of HIV/AIDS in Taiwan

  • Yi-Horng LaiEmail author
Conference paper
Part of the Communications in Computer and Information Science book series (CCIS, volume 540)


Comorbidities are the presence of one or more additional disorders or diseases co-occurring with a primary disease or disorder. The purpose of this study is to identify diseases that co-occur with HIV/AIDS and analyze the gender differences. Data was collected from 536 HIV/AIDS admission medical records out of 1,377,469 admission medical records from 1997 to 2010 in Taiwan. In this study, the comorbidity relationships are presented in the phenotypic disease network (PDN), and φ-correlation is used to measure the distance between two diseases on the network. The results show that there is a high correlation in the following pairs/triad of diseases: human immunodeficiency virus infection with specified conditions (042) and pneumocystosis pneumonia (1363), human immunodeficiency virus infection with specified malignant neoplasms (0422) and kaposi’s sarcoma of other specified sites (1768), human immunodeficiency virus acquired immunodeficiency syndrome, and unspecified (0429) and progressive multifocal leukoencephalopathy (0463), and lastly, human immunodeficiency virus infection with specified infections (0420), meningoencephalitis due to toxoplasmosis (1300), and human immunodeficiency virus infection specified infections causing other specified infections (0421).


Phenotypic disease network (PDN) HIV/AIDS Network analysis 


  1. 1.
    Taiwan Centers for Disease Control: Communicable Diseases & Prevention-HIV/AIDS, Health topics. (retrieved January 20, 2015)
  2. 2.
    Hidalgo, C.A., Blumm, N., Barabási, A.L., Christakis, N.A.: A Dynamic Network Approach for the Study of Human Phenotypes. PLoS Computational Biology 5(4), 1–11 (2009)CrossRefGoogle Scholar
  3. 3.
    Goh, K.I., Cusick, M.E., Valle, D., Barton, C., Vidal, M., Barabási, A.L.: The Human Disease Network. Proceedings of the National Academy of Sciences of the United States of America 104(21), 8685–8690 (2007)CrossRefGoogle Scholar
  4. 4.
    Santiago, J.A., Potashkin, J.A.: A Network Approach To Clinical Intervention In Neurodegenerative Diseases. Trends in Molecular Medicine 20(12), 694–703 (2014)CrossRefGoogle Scholar
  5. 5.
    Tarín, J.J., García-Pérez, M.A. Hamatani, T., Cano, A.: Infertility Etiologies Are Genetically and Clinically Linked With Other Diseases in Single Meta-Diseases. Reproductive Biology and Endocrinology 13 (2015). (retrieved April 20, 2015)
  6. 6.
    Moni, M.A., Liò, P.: Network-Based Analysis of Comorbidities Risk During an Infection: SARS and HIV Case Studies. BMC Bioinformatics 15, 1471–2105 (2014)CrossRefGoogle Scholar
  7. 7.
    Iezzoni, L.I., Heeren, T., Foley, S.M., Daley, J., Hughes, J., Coffman, G.A.: Chronic Conditions and Risk of In-Hospital Death. Health Services Research 29(4), 435–460 (1994)Google Scholar
  8. 8.
    Schneeweiss, S., Wang, P.S., Avorn, J., Glynn, R.J.: Improved Comorbidity Adjustment for Predicting Mortality in Medicare Populations. Health Services Research 38(4), 1103–1120 (2003)CrossRefGoogle Scholar
  9. 9.
    Rzhetsky, A., Wajngurt, D., Park, N., Zheng, T.: Probing Genetic Overlap among Complex Human Phenotypes. Proceedings of the National Academy of Sciences of the United States of America 104(28), 11694–11699 (2007)CrossRefGoogle Scholar
  10. 10.
    National Health Research Institutes: National Health Insurance Research Database (NHIRD). (retrieved December 1, 2014)
  11. 11.
    Centers for Disease Control and Prevention. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). (retrieved December 1, 2014)
  12. 12.
    Ekström, J.: The Phi-coefficient, the Tetrachoric Correlation Coefficient, and the Pearson-Yule Debate. (retrieved February 20, 2015)
  13. 13.
    Aliouat-Denis, C.M., Chabé, M., Demanche, C., el Aliouat, M., Viscogliosi, E., Guillot, J., Delhaes, L., Dei-Cas, E.: Pneumocystis Species, Co-Evolution and Pathogenic Power. Infection, Genetics and Evolution 8(5), 708–726 (2008)CrossRefGoogle Scholar
  14. 14.
    Dubey, J.P., Hill, D.E., Jones, J.L., Hightower, A.W., Kirkland, E., Roberts, J.M., Marcet, P.L., Lehmann, T., Vianna, M.C., Miska, K., Sreekumar, C., Kwok, O.C., Shen, S.K., Gamble, H.R.: Prevalence Of Viable Toxoplasma Gondii in Beef, Chicken, and Pork from Retail Meat Stores in The United States: Risk Assessment to Consumers. The Journal of Parasitology 91(5), 1082–1093 (2005)CrossRefGoogle Scholar
  15. 15.
    Holmes, A.B., Hawson, A., Liu, F., Friedman, C., Khiabanian, H., Rabadan, R.: Discovering Disease Associations by Integrating Electronic Clinical Data and Medical Literature. PLoS ONE 6(6), 1–11 (2011)CrossRefGoogle Scholar
  16. 16.
    Casado, J.L., Corral, I., García, J.: Martinez-San Millán, J., Navas, E., Moreno, A., & Moreno, S.: Continued Declining Incidence and Improved Survival of Progressive Multifocal Leukoencephalopathy in HIV/AIDS Patients in The Current Era. European Journal of Clinical Microbiology & Infectious Diseases 33(2), 179–187 (2014)CrossRefGoogle Scholar
  17. 17.
    Sano, Y., Nakano, Y., Omoto, M., Takao, M., Ikeda, E., Oga, A., Nakamichi, K., Saijo, M., Maoka, M., Sano, H., Kawai, M., Kanda, T.: Rituximab-associated Progressive Multifocal Leukoencephalopathy Derived from Non-Hodgkin Lymphoma: Neuropathological Findings and Results of Mefloquine Treatment. Internal Medicine 54(8), 965–970 (2015)CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Department of Health Care AdministrationOriental Institute of TechnologyNew Taipei CityTaiwan

Personalised recommendations